| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Anavex Life Sciences Corp. (AVXL) has 3 insiders with recent SEC Form 4 filings, including 10 buys and 0 sells. AVXL is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 125.0K | $387.5K | - | |
| Other | 12.5K | $38.8K | - | |
| Dir | 0 | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 5, 2017 | Missling Christopher U | President And CEO | Buy | 375 | $4.30 | $1,612.50 | - | |
| Oct 2, 2017 | Missling Christopher U | President And CEO | Buy | 375 | $4.20 | $1,575.00 | - | |
| Sep 28, 2017 | Missling Christopher U | President And CEO | Buy | 375 | $4.21 | $1,578.75 | - | |
| Sep 26, 2017 | Missling Christopher U | President And CEO | Buy | 375 | $3.88 | $1,455.00 | - | |
| Sep 20, 2017 | Missling Christopher U | President And CEO | Buy | 375 | $4.23 | $1,586.25 | - | |
| Sep 18, 2017 | Missling Christopher U | President And CEO | Buy | 375 | $4.40 | $1,650.00 | - | |
| Sep 14, 2017 | Missling Christopher U | President And CEO | Buy | 375 | $4.58 | $1,717.50 | - | |
| Sep 11, 2017 | Missling Christopher U | President And CEO | Buy | 375 | $4.81 | $1,803.75 | - | |
| Sep 7, 2017 | Missling Christopher U | President And CEO | Buy | 375 | $4.76 | $1,785.00 | - | |
| Sep 5, 2017 | Missling Christopher U | President And CEO | Buy | 375 | $4.90 | $1,837.50 | - |